The Chicago Tribune (2/8, Metz) reported that “next month, the drug company Allergan — the folks who brought us Botox (botulinum toxin type A) — will begin offering a product called Latisse (bimatoprost ophthalmic solution). When applied to the upper lash line daily, the drug has been shown to lengthen and thicken eyelashes.” Latisse “contains the same active ingredients as the drug Lumigan (bimatoprost ophthalmic), an eyedrop that’s used to treat a specific type of glaucoma. Over the years, patients using Lumigan reported increased eyelash growth as a side effect.” A “one-month supply” will cost $120, and “will be packaged with small brushes that” are to be dipped “in the solution and then” applied “on the base of the lashes.” Latisse will be available “by prescription only. Even if you have a plastic surgeon or dermatologist, see an ophthalmologist first,” because “certain eye conditions could mean you’re not a candidate,” the article advised.